ArticleBMC medicine2022

Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling.

Seul-Gee Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.